
<html>
<head>
	<meta charset="ja"/>
	<title>臨床試験登録</Title>
	<meta name="keywords" content="#"/>
	<meta name="description" content="#"/>
	<meta HTTP-EQUIV="Content-type" CONTENT="text/html; charset=UTF-8">
</Head>
<Body bgcolor="#FFFFFF" LANG="ja" TEXT="#000000">
<table border="0" style="word-break:break-all;">
<tr>
<td><img src="/image2/icon.gif" /></td>
<td><h1><b><font color="#6A5ACD">UMIN-CTR 臨床試験登録情報の閲覧</font></b></h1></td>
</tr>
</table>
<table border="0" style="word-break:break-all;">
<tr>
<td><table bgcolor="#FFCCCC" bordercolor="#FFFFFF" border="1">
<tr>
<th width="50"><a href="JavaScript:history.back();"><font size="-1">BACK</font></a></th>
<th width="50"><a href="http://www.umin.ac.jp/"><font size="-1">TOP</font></a></th>
</tr>
</table>
</td>
<td><img src="/images/Balls/blue.gif" /> <a href="http://www.umin.ac.jp/ctr/index-j.htm">UMIN-CTR ホーム</a></td>
<td><img src="/images/Balls/blue.gif" /> <a href="http://www.umin.ac.jp/ctr/UMIN-CTR_Yougo.htm">用語の説明（簡易版）</a></td>
<td><img src="/images/Balls/blue.gif" /> <!a href="http://www.umin.ac.jp/ctr/UMIN-CTR_Yougo.htm">用語の説明（詳細版）--準備中<!/a></td>
<td><img src="/images/Balls/blue.gif" /> <a href="http://www.umin.ac.jp/ctr/UMIN-CTR_FAQ.htm">ＦＡＱ</a></td>
</tr>
</table>
<hr color="#CCCCFF" size="3" />
<table border="0" style="word-break:break-all;">
<tr>
<td bgcolor="#FFFF99" align="center" width="100"><b><font color="#000000">利用者名：</font></b></td>
<td bgcolor="#FFFFDD" width="160"></td>
<td width="10"><br /></td>
<td bgcolor="#FFFF99" align="center" width="100"><b><font color="#000000">UMIN ID：</font></b></td>
<td bgcolor="#FFFFDD" width="160"></td>
</tr>
</table>
<br />
<table border="0" style="word-break:break-all;" width="100%">
<tr>
<td bgcolor="#FFFF99" align="center" width="200"><b><font color="#000000">試験進捗状況</font></b></td>
<td bgcolor="#FFFFDD">限定募集中/Enrolling by invitation</td>
</tr>
<tr>
<td bgcolor="#FFFF99" align="center" width="200"><b><font color="#000000">UMIN試験ID</font></b></td>
<td bgcolor="#FFFFDD">UMIN000027821</td>
</tr>
<tr>
<td bgcolor="#FFFF99" align="center" width="200"><b><font color="#000000">受付番号</font></b></td>
<td bgcolor="#FFFFDD">R000031865</td>
</tr>
<tr>
<td bgcolor="#FFFF99" align="center"><b><font color="#000000">科学的試験名</font></b></td>
<td bgcolor="#FFFFDD">第1・第2 寛解期小児急性骨髄性白血病を対象としたフルダラビン・シタラビン・メルファラン・低線量全身照射による前処置置を用いた同種移植の安全性・有効性についての臨床試験（AML-SCT15）</td>
</tr>
<tr>
<td bgcolor="#FFFF99" align="center" width="100"><b><font color="#000000">一般公開日（本登録希望日）</font></b></td>
<td bgcolor="#FFFFDD">2017/07/01</td>
</tr>
<tr>
<td bgcolor="#FFFF99" align="center" width="100"><b><font color="#000000">最終更新日</font></b></td>
<td bgcolor="#FFFFDD">2017/12/19</td>
</tr>
</table>
<br />
<font color="#FF0000" size="-1">※  本ページ収載の情報は、臨床試験に関する情報公開を目的として、UMINが開設しているUMIN臨床試験登録システムに提供された臨床試験情報です。<br>※  特定の医薬品や治療法等については、医療関係者や一般の方に向けて広告することは目的としていません。</font>
<br />
<br />
<div align="center">
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">基本情報/Basic information</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">一般向け試験名/Public title</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">第1・第2 寛解期小児急性骨髄性白血病を対象としたフルダラビン・シタラビン・メルファラン・低線量全身照射による前処置置を用いた同種移植の安全性・有効性についての臨床試験（AML-SCT15）</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Phase II study of allogeneic hematopoietic cell transplantation for children with acute myeloid leukemia in first and second complete remission using fludarabine, cytarabine, melphalan and low-dose total body irradiation as a conditioning regimen (AML-SCT15).</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">一般向け試験名略称/Acronym</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">AML-SCT15</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">AML-SCT5</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">科学的試験名/Scientific Title</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">第1・第2 寛解期小児急性骨髄性白血病を対象としたフルダラビン・シタラビン・メルファラン・低線量全身照射による前処置置を用いた同種移植の安全性・有効性についての臨床試験（AML-SCT15）</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Phase II study of allogeneic hematopoietic cell transplantation for children with acute myeloid leukemia in first and second complete remission using fludarabine, cytarabine, melphalan and low-dose total body irradiation as a conditioning regimen (AML-SCT15).</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">科学的試験名略称/Scientific Title:Acronym</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">AML-SCT15</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">AML-SCT5</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">試験実施地域/Region</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">日本/Japan</td>
<td style="background-color:transparent;">南米/South America</td>
</tr>
<tr>
</tr>
</table>
</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">対象疾患/Condition</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">対象疾患名/Condition</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">急性白血病</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">acute myeloid leukemia (AML)</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">疾患区分1/Classification by specialty</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">血液・腫瘍内科学/Hematology and clinical oncology</td>
<td style="background-color:transparent;">小児科学/Pediatrics</td>
</tr>
<tr>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">疾患区分2/Classification by malignancy</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">悪性腫瘍/Malignancy</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">ゲノム情報の取扱い/Genomic information</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">はい/YES</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">目的/Objectives</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">目的1/Narrative objectives1</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">本試験では第1寛解(CR1)を維持している高リスク(HR)群の小児急性骨髄性白血病（AML）症例および第2寛解(CR2)を維持しているAML 症例に対する初回移植として、骨髄破壊強度を保ちつつ高線量の全身照射(total body irradiation; TBI)とbusulfan(Bu)を避けたフルダラビン・シタラビン・メルファラン・低線量全身照射を用いたreduced-intensity stem<br>cell transplantation (RIST)の安全性と有効性、および晩期合併症の評価を目的とする。<br></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">To investigate safety and efficacy of reduced-intensity/toxicity stem cell transplantation using fludarabine, cytarabine, melphalan and low-dose total body irradiation as a substantial myeloablative conditioning regimen (FLAMEL) for children with high-risk AML in first complete remission or AML in second complete remission.</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">目的2/Basic objectives2</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">安全性・有効性/Safety,Efficacy</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">目的2 -その他詳細/Basic objectives -Others</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験の性質1/Trial characteristics_1</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">検証的/Confirmatory</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験の性質2/Trial characteristics_2</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">実務的/Pragmatic</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験のフェーズ/Developmental phase</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">第Ⅱ相/Phase II</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">評価/Assessment</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">主要アウトカム評価項目/Primary outcomes</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">移植後3 年全生存率</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Probability of overall survival rate at three years after transplantation</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">副次アウトカム評価項目/Key secondary outcomes</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">1) 有効性<br>移植後3 年無イベント生存率<br>移植後3 年再発率<br>移植後3 年非再発死亡率<br>移植後10 年全生存率<br>移植後10 年無イベント生存率<br>移植後10 年再発率<br>移植後10 年非再発死亡率<br>移植後3 年、10 年の死因の解析<br>再移植を施行した症例の頻度<br>二次がんの発症頻度<br>(2) 短期安全性（移植後100 日まで）<br>移植後100 日の生着率<br>移植後100 日の二次生着不全率<br>移植後100 日非再発死亡率<br>急性GVHD の発症頻度・重症度<br>ドナーリンパ球輸注の施行の適用分類<br>肝類洞閉塞症候群（SOS）、血栓性微小血管症（TMA）の発生状況<br>FLAMEL レジメン使用症例の移植後1 か月・3 か月のキメリズム割合<br>KIR リガンド不一致臍帯血移植を施行した症例における重症感染症の解析<br>前処置から移植完了4 週後までの前処置毒性（Bearman 基準）の解析<br>移植後100 日のgrade 3 以上の有害事象（CTCAE）の解析<br>移植後100 日の38 度以上の有熱日数<br>(3) 晩期安全性<br>移植後100 日の翌日～移植後1 年の生着率<br>移植後100 日の翌日～移植後1 年の二次生着不全率<br>移植後100 日の翌日～移植後1 年のドナーリンパ球輸注の施行の適用分類<br>移植後100 日の翌日～移植後1 年の肝類洞閉塞症候群（SOS）、血栓性微小血管症（TMA）の発生状況<br>慢性GVHD の発症頻度・重症度<br>身長(SD)、体重(SD)の継時推移<br>成長ホルモン未投与症例の身長(SD)の解析<br>TSH、F-T4、LH、FSH、Testosterone、Estradiol、AMH、Tanner stage の継時推移月経発来の有無<br>移植後3 年、10 年の成長障害、甲状腺機能障害、性腺機能障害<br>移植後1 年のgrade 3 以上の有害事象（CTCAE）の解析<br></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">1) Efficacy<br>Probability of event-free survival (EFS) rate, <br>Cumulative incidence of relapse and <br>non-relapse mortality (NRM) at 3 years after transplantation<br>Probability of overall survival (OS) rate,<br>EFS rate,<br>Cumulative incidence of relapse and <br>NRM at 10 years after transplantation<br>Profile of cause of death at 3 and 10 years after transplantation<br>Incidence of second transplantation and <br>second malignant neoplasms<br>2) Short-term safety (up to 100 days after transplantation)<br>Cumulative incidence of engraftment, <br>secondary graft failure (2nd GF) and<br>NRM at 100 days after transplantation<br>Cumulative incidence and severity of acute and chronic graft-versus-host disease (GVHD), <br>sinusoidal obstruction syndrome (SOS) and thrombotic microangiopathy (TMA)<br>Incidence of and reason for donor lymphocyte infusion (DLI)<br>Monitoring of chimerism at 1 and 3 months after FLAMEL regimen<br>Profile of severe infectious disease after KIR ligand-mismatched cord blood transplantation<br>Profile of conditioning regimen-related toxicities (Bearman criteria) up to 4 weeks after transplantation<br>Profile of CTCAE (grade &gt;=3) <br>Cumulative days of fever (&gt;=38C)<br>3) Long-term safety<br>Cumulative incidence of engraftment,<br>2nd GF,  <br>SOS and TMA up to 1 year after transplantation<br>Incidence of and reason for DLI up to one year after transplantation<br>Cumulative incidence and severity of acute and chronic GVHD<br>Monitoring of height (SD) and body weight (SD) after transplantation <br>Monitoring of height (SD) of patients untreated with growth hormone <br>Monitoring of TSH, free-T4, LH, FSH, testosterone, estradiol and anti-mullerian hormone<br>Monitoring of Tanner stage and menstruation<br>Incidence of growth disturbance, thyroid dysfunction and gonadal dysfunction at 3 and 10 years after transplantation<br>Profile of CTCAE (grade &gt;=3) up to 1 year after transplantation<br></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">基本事項/Base</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">試験の種類/Study type</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">介入/Interventional</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">試験デザイン/Study design</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">基本デザイン/Basic design</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">並行群間比較/Parallel</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">ランダム化/Randomization</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">非ランダム化/Non-randomized</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">ランダム化の単位/Randomization unit</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">ブラインド化/Blinding</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">オープン/Open -no one is blinded</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">コントロール/Control</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">実薬・標準治療対照/Active</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">層別化/Stratification</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">いいえ/NO</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">動的割付/Dynamic allocation</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">いいえ/NO</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験実施施設の考慮/Institution consideration</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">施設を考慮していない/Institution is not considered as adjustment factor.</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">ブロック化/Blocking</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">割付コードを知る方法/Concealment</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">知る必要がない/No need to know</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">介入/Intervention</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">群数/No. of arms</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">2</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">介入の目的/Purpose of intervention</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">治療・ケア/Treatment</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">介入の種類/Type of intervention</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">医薬品/Medicine</td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">介入1/Interventions/Control_1</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">FLAMEL regimen:リン酸フルダラビン(30 mg/square meter×1回/日を4日間)と、シタラビン（2 g/square meter×1回/日を2日間）、メルファラン（60 mg/square を3日間）、全身照射（3 Gy 1ｘ1/日）<br>移植片は骨髄、末梢血幹細胞、臍帯血のいずれも選択できる。原則的に，タクロリムスまたはシクロスポリンとメソトレキサートを用いたGVHD予防を行う。</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">FLAMEL regimen: fludarabine (30 mg/m^2 x 1/day for 4 days), cytarabine (2 g/m^2 x 1/day for 4 days), melphalan (60 mg/m^2 x 1/day for 3 days) and low-dose total body irradiation (2 Gy x 1/day for one day) <br>Graft: any of bone marrow, peripheral stem cell and cord blood. <br>Graft-versus-host disease (GVHD) prophylaxis: in essentially tacrolimus or cyclosporine in combination with methotrexate. <br></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入2/Interventions/Control_2</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">副次的項目の評価のために、コントロールとして骨髄髄破壊的量のブスルファン（&gt; 8 mg/kg）または全身照射（&gt;= 8 Gy, fractionated）を用いた前処置後の造血細胞移植を受けた症例が登録される。<br>移植片は骨髄、末梢血幹細胞、臍帯血のいずれも選択できる。原則的に，タクロリムスまたはシクロスポリンとメソトレキサートを用いたGVHD予防を行う。</td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">For evaluation of secondary endo-points, patients received allogeneic transplantation using myeloablative conditioning regimens consisting of busulfan (&gt; 8 mg/kg) or total body irradiation (&gt;= 8 Gy, fractionated) are also enrolled to this study.<br>Graft: any of bone marrow, peripheral stem cell and cord blood. <br>Graft-versus-host disease (GVHD) prophylaxis: in essentially tacrolimus or cyclosporine in combination with methotrexate. <br><br></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入3/Interventions/Control_3</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入4/Interventions/Control_4</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入5/Interventions/Control_5</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入6/Interventions/Control_6</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入7/Interventions/Control_7</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入8/Interventions/Control_8</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入9/Interventions/Control_9</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">介入10/Interventions/Control_10</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">適格性/Eligibility</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">年齢（下限）/Age-lower limit</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;" cellpadding="1" cellspacing="1">
<tr>
<td><br /></td>
<td>適用なし/Not applicable</td>
<td><br /></td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">年齢（上限）/Age-upper limit</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;" cellpadding="1" cellspacing="1">
<tr>
<td>20</td>
<td>歳/years-old</td>
<td>未満/&gt;</td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">性別/Gender</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">男女両方/Male and Female</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">選択基準/Key inclusion criteria</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">下記すべてを満たしている症例<br>1)AML(ただし、APL、ダウン症候群に発症した全てのAML、二次性AML、MDS より進展したAML、NK/myeloid leukemia、および顆粒球肉腫は除く)<br>2)JPLSG の前方視的研究(JPLSG-CHM-14)の登録がなされた症例<br>3)初発AML に対する化学療法が施行され、CR1 を維持している高リスク症例*、または初回骨髄再発（髄外同時再発を含む）したAML に対し化学療法にてCR2 を維持している症例<br>*高リスク群の定義<br>初発診断時検査にてモノソミー7、5q-、t(16;21)(p11;q22)/FUS-ERG、<br>t(9;22)(q34;q11.2)/BCR-ABL，t(6;11)(q27;q23)/MLL-MLLT4(AF6)、FLT3-ITD、NUP98-NSD1のいずれかが陽性、または寛解導入療法 1 後の骨髄芽球比率が 5 %以上(M2/M3 marrow)、または髄外浸潤陽性<br>4)初発時(AML 診断時)年齢が18 歳未満の症例<br>5)再発症例については、再発時(AML 再発診断時)年齢が20 歳未満の症例<br>6)本試験参加について本人および/又は代諾者から文書で同意（アセントも含む）が得られ<br>た症例<br>7)造血細胞移植の適応があると考えられる症例<br>8)ECOG のPerformance status が0-2<br>9)登録前28 日以内における臓器機能検査結果が以下の基準をすべて満たす。<br>(a) コントロールされていない心不全がなく、かつ左室駆出率50 %以上<br>(b) 肺機能検査の一秒率が50 %以上かつ予測肺活量50 %以上。ただし肺機能検査が不可<br>能な場合には、酸素投与を必要とせずSpO2 95％以上<br>(c) AST/ALT が5 xULN 未満(CTCAE grade 2 以下)かつT.Bil 3xULN 未満(CTCAE grade 2以下)<br>(d) コントロールされていない腎不全がなく、血清クレアチニンが2 xULN 未満<br><br></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Inclusion criteria<br>1)	1)	AML (acute promyelocytic leukemia, AML which developed in patients with Down syndrome, secondary AML, AML which developed in patients with myelodysplastic syndrome, NK/myeloid leukemia and granulocytic leukemia are excluded)<br>2)	Cases registered in the prospective study in JPLSG (JPLSG CHM-14)<br>3)	Patients with high-risk AML in first complete remission or bone marrow-relapsed patients with AML in second complete remission <br>4)	High-risk AML<br>Any of the following<br>a)	Unfavorable chromosome abnormality including -7, del(5q)/-5, t(16;21)(p11;q22)/FUS-ERG, t(9;22)(q34;q11.2)/BCR-ABL1 or t(6;11)(q27;q23)/MLL-MLLT4(AF6), or unfavorable genetic abnormality including FLT3-ITD or NUP98-NSD1<br>b)	Blast ratio &gt;=5% in the bone marrow (M2/M3 marrow) after the first induction therapy<br>c)	Extramedullary lesions after the first induction therapy<br>5)	Patients less than 18 years at the initial diagnosis in first remission, or patients less than 20 years at the relapse diagnosis in second remission<br>6)	Written informed consent has been acquired from patients and/or persons with parental authority. <br>7)	Cases in which a suitable donor is available and hematopoietic cell transplantation is considered to be mandatory<br>8)	Patients whose performance status are 0 or 2 by ECOG criteria<br>9)	Patients who satisfactory meet all of the following criteria about organ functions within 28 days prior to registration<br>a) Patients without uncontrolled cardiac failure and ejection fraction of left ventricle &gt;= 50% by UCG<br>b) %VC &gt;= 50% and FEV1.0% &gt;= 50%, or SpO2 &gt;= 95% by room air if pulmonary function tests are impossible<br>c) AST/ALT &lt; 5 x upper limit of normal range (CTCAE &lt; grade 2)<br>d) Patients without uncontrolled renal failure and sCr &lt; 2 x upper limit of normal range</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">除外基準/Key exclusion criteria</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">次の項目のいずれかに該当する症例は本試験の対象としない。<br>(1)髄外浸潤が残存する。<br>(2)放射線照射の既往がある。<br>JPLSG-AML-SCT15 v0.20170616<br>32<br>(3)同種造血幹細胞移植の既往がある。<br>(4)コントロール不能な感染症を伴う。<br>(5)試験治療に支障を来す先天性疾患や精神疾患を有する。<br>(6)重複がんを有する。<br>(7)前治療法に用いる薬剤、ならびに急性GVHD 予防に用いる薬剤に対し過敏症の既往がある。<br>(8)妊娠中、または妊娠の可能性がある。<br>(9)その他、治療施行に支障を来すと担当医が判断した場合。<br></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Exclusion criteria<br>1)	Patients who have extramedullary lesions at registry<br>2)	Patients who have prior radiation therapy<br>3)	Patients who have prior hematopoietic cell transplantation<br>4)	Patients who have poorly controlled infectious disease<br>5)	Patients who have psychiatric disorder<br>6)	Patients who have coinciding malignancies<br>7)	Patients who have an episode of hypersensitivity reactions against drugs used in conditioning regimens and/or GVHD prophylaxis<br>8)	Pregnant women or women who may be pregnant<br>9)	Patients who are considered as inappropriate for this trial by attending physicians<br><br></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">目標参加者数/Target sample size</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">66</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">責任研究者/Research contact person</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">責任研究者/Name of lead principal investigator</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><table border="0" style="word-break:break-all;" cellpadding="1" cellspacing="1" width="100%">
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">名</font></b></td>
<td><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA"><b><font color="#6A5ACD">ミドルネーム</font></b></td>
<td bgcolor="#E6E6FA"><br /></td>
</tr>
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">姓</font></b></td>
<td>矢部　普正</td>
</tr>
</table>
</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><table border="0" style="word-break:break-all;" cellpadding="1" cellspacing="1" width="100%">
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">名</font></b></td>
<td><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA"><b><font color="#6A5ACD">ミドルネーム</font></b></td>
<td bgcolor="#E6E6FA"><br /></td>
</tr>
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">姓</font></b></td>
<td>Hiromasa Yabe</td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">所属組織/Organization</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">東海大医学部</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Tokai University, School of Medicine</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">所属部署/Division name</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">基盤診療学系再生医療科学</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Department of Cell Transplantation and Regenerative Medicine</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">郵便番号/Zip code</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">住所/Address</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">〒 259-1193 神奈川県伊勢原市下糟屋143</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">143, Shimokasuya, Isehara, Japan </td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">電話/TEL</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">0463-93-1121</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">Email/Email</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">yabeh@is.icc.u-tokai.ac.jp</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">試験問い合わせ窓口/Public contact </font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">試験問い合わせ窓口担当者/Name of contact person</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><table border="0" style="word-break:break-all;" cellpadding="1" cellspacing="1" width="100%">
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">名</font></b></td>
<td><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA"><b><font color="#6A5ACD">ミドルネーム</font></b></td>
<td bgcolor="#E6E6FA"><br /></td>
</tr>
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">姓</font></b></td>
<td>石田宏之／梅田勝嗣</td>
</tr>
</table>
</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><table border="0" style="word-break:break-all;" cellpadding="1" cellspacing="1" width="100%">
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">名</font></b></td>
<td><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA"><b><font color="#6A5ACD">ミドルネーム</font></b></td>
<td bgcolor="#E6E6FA"><br /></td>
</tr>
<tr>
<td style="background-color:transparent;"><b><font color="#6A5ACD">姓</font></b></td>
<td>Hiroyuki Ishida / Katsutsugu Umeda</td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">組織名/Organization</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">京都市立病院／京都大学医学部</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Kyoto City Hospital / Graduate School of Medicine, Kyoto University</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">部署名/Division name</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">小児科／発達小児科学</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Department of Pediatrics / Department of Pediatrics</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">郵便番号/Zip code</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">住所/Address</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">〒604-8845  京都市中京区壬生高田町１－２／〒 606-8507 京都市左京区聖護院河原町５４</td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">1-2, Higashitakada-cho, Mibu, Nakagyou-ku, Kyoto / 54, Kawahara-cho, Shogoin, Sakyou-ku, Kyoto</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">電話/TEL</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">075-311-5311.075-751-3290</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験のホームページURL/Homepage URL</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">http://jplsg.jp/menu0_contents/index_menu_0.htm</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">Email/Email</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">ishidah@koto.kpu-m.ac.jp</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">実施責任組織/Sponsor</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">機関名/Institute</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">その他
</td>
<td bgcolor="#FFF0F5" rowspan="3" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Japan Children&#39;s Cancer Group (JCCG)</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">機関名/Institute<br>（機関選択不可の場合）</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">日本小児がん研究グループ　</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">部署名/Department</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">血液分科会（JPLSG）</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">研究費提供組織/Funding Source</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">機関名/Organization</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">国立研究開発法人日本医療研究開発機構
</td>
<td bgcolor="#FFF0F5" rowspan="3" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Japan Agency for Medical Research and Development</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">機関名/Organization<br>（機関選択不可の場合）</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">組織名/Division</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">組織の区分/Category of Funding Organization</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">日本の官庁/Japanese Governmental office</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">研究費拠出国/Nationality of Funding Organization</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">日本</td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%">Japan</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">その他の関連組織/Other related organizations</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">共同実施組織/Co-sponsor</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">その他の研究費提供組織/Name of secondary funder(s)</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">IRB等連絡先（公開）/IRB Contact (For public release)</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">組織名/Organization</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">住所/Address</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">電話/Tel</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">Email/Email</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">他機関から発行された試験ID/Secondary IDs</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">他機関から発行された試験ID/Secondary IDs</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">いいえ/NO</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験ID1/Study ID_1</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">ID発行機関1/Org. issuing International ID_1</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験ID2/Study ID_2</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">ID発行機関2/Org. issuing International ID_2</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">治験届/IND to MHLW</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">試験実施施設/Institutions</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">試験実施施設名称/Institutions</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">日本小児血液・がん研究組織参加施設</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">その他の管理情報/Other administrative information</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">一般公開日（本登録希望日）/Date of disclosure of the study information</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">2017</td>
<td style="background-color:transparent;">年</td>
<td style="background-color:transparent;">07</td>
<td style="background-color:transparent;">月</td>
<td style="background-color:transparent;">01</td>
<td style="background-color:transparent;">日</td>
</tr>
</table>
</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">関連情報/Related information</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">プロトコル掲載URL/URL releasing protocol</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">試験結果の公開状況/Publication of results</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">未公表/Unpublished</td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">結果/Result</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">結果掲載URL/URL related to results and publications</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">組み入れ参加者数/Number of participants that the trial has enrolled</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">主な結果/Results</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">主な結果入力日/Results date posted</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">結果掲載遅延/Results Delayed</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">結果遅延理由/Results Delay Reason</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">最初の試験結果の出版日/Date of the first journal publication of results</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">参加者背景/Baseline Characteristics</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">参加者の流れ/Participant flow</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">有害事象/Adverse events</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">評価項目/Outcome measures</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">個別症例データ共有計画/Plan to share IPD</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">個別症例データ共有計画の詳細/IPD sharing Plan description</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">試験進捗状況/Progress</font></b></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">試験進捗状況/Recruitment status</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%">限定募集中/Enrolling by invitation</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">プロトコル確定日/Date of protocol fixation</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">2017</td>
<td style="background-color:transparent;">年</td>
<td style="background-color:transparent;">06</td>
<td style="background-color:transparent;">月</td>
<td style="background-color:transparent;">16</td>
<td style="background-color:transparent;">日</td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">倫理委員会による承認日/Date of IRB</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">登録・組入れ開始（予定）日/Anticipated trial start date</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">2017</td>
<td style="background-color:transparent;">年</td>
<td style="background-color:transparent;">07</td>
<td style="background-color:transparent;">月</td>
<td style="background-color:transparent;">01</td>
<td style="background-color:transparent;">日</td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#FFF0F5" align="center" width="20%"><b><font color="#6A5ACD">フォロー終了(予定)日/Last follow-up date</font></b></td>
<td bgcolor="#FFF0F5" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">入力終了(予定)日/Date of closure to data entry</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">データ固定（予定）日/Date trial data considered complete</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">解析終了(予定)日/Date analysis concluded</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><br /></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">その他/Other</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">その他関連情報/Other related information</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" valign="top" style="word-wrap:break-word;" colspan="1" width="40%"><br /></td>
</tr>
</table>
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="3" width="100%"><b><font color="#6A5ACD">管理情報/Management information</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">登録日時/Registered date</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">2017</td>
<td style="background-color:transparent;">年</td>
<td style="background-color:transparent;">06</td>
<td style="background-color:transparent;">月</td>
<td style="background-color:transparent;">19</td>
<td style="background-color:transparent;">日</td>
</tr>
</table>
</td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">最終更新日/Last modified on</font></b></td>
<td bgcolor="#E6E6FA" rowspan="1" align="left" style="word-wrap:break-word;" colspan="2" width="80%"><table border="0" style="word-break:break-all;">
<tr>
<td style="background-color:transparent;">2017</td>
<td style="background-color:transparent;">年</td>
<td style="background-color:transparent;">12</td>
<td style="background-color:transparent;">月</td>
<td style="background-color:transparent;">19</td>
<td style="background-color:transparent;">日</td>
</tr>
</table>
</td>
</tr>
</table>
<br />
<br />
<table bordercolor="#9999FF" border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="100%">
<tr>
<td bgcolor="#E6E6FA" align="center" colspan="2" width="100%"><b><font color="#6A5ACD">閲覧ページへのリンク/Link to view the page</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">URL(日本語)</font></b></td>
<td bgcolor="#E6E6FA" align="left" width="40%"><font color="#006600">https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000031865</font></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="20%"><b><font color="#6A5ACD">URL(英語)</font></b></td>
<td bgcolor="#E6E6FA" align="left" width="40%"><font color="#006600">https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031865</font></td>
</tr>
</table>
<br />
<table border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="800">
<tr>
<td bgcolor="#E6E6FA" align="center" width="800" colspan="2"><b><font color="#6A5ACD" size="2">研究計画書</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="100"><b><font color="#6A5ACD" size="2">登録日時</font></b></td>
<td bgcolor="#E6E6FA" align="center" width="500"><b><font color="#6A5ACD" size="2">ファイル名</font></b></td>
</tr>
</table>
<br />
<table border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="800">
<tr>
<td bgcolor="#E6E6FA" align="center" width="800" colspan="2"><b><font color="#6A5ACD" size="2">研究症例データ仕様書</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="100"><b><font color="#6A5ACD" size="2">登録日時</font></b></td>
<td bgcolor="#E6E6FA" align="center" width="500"><b><font color="#6A5ACD" size="2">ファイル名</font></b></td>
</tr>
</table>
<br />
<table border="1" style="word-break:break-all;" cellpadding="5" cellspacing="0" width="800">
<tr>
<td bgcolor="#E6E6FA" align="center" width="800" colspan="2"><b><font color="#6A5ACD" size="2">研究症例データ</font></b></td>
</tr>
<tr>
<td bgcolor="#E6E6FA" align="center" width="100"><b><font color="#6A5ACD" size="2">登録日時</font></b></td>
<td bgcolor="#E6E6FA" align="center" width="500"><b><font color="#6A5ACD" size="2">ファイル名</font></b></td>
</tr>
</table>
<br />
<form method="post" action="ctr_view.cgi" enctype="multipart/form-data" name="main_form">

<input type="button"  value="戻る" onclick="history.back();" style="margin-left:10px;width: 250px;height: 70px;font-size: 22px;" class="BUTTON" />
</form>
</div>
<hr color="#CCCCFF" size="3" />
<div align="left">
UMIN臨床試験登録システムのご使用に関するお問い合わせは、<A HREF="http://www.umin.ac.jp/ctr/UMIN-CTR_question.htm" target="_blank">こちらのお問い合わせフォーム</A> からお願いいたします。それ以外のお問い合わせは、<a href="http://www.umin.ac.jp/faq/"> こちら </a>よりお願い致します。
<br />
<img src="/image2/banner.gif" />
</div>

</body>
</html>
